discovery
AstraZeneca: Helping SMEs overcome bottlenecks in early drug discovery
October 23 by Pharmaceuticals & Biotechnology EditorMedicines Discovery Catapult & AstraZeneca collaborate to give SMEs access to Acoustic Mist Ionization Mass Spectrometry in drug discovery
Drugs and Products to Watch in 2018: Part 2
July 10 by Regina AuYou may remember reading Regina's previous article about immuno-oncology in 2018. Regina is back again to discuss key developments in gene editing and heart failure devices.Gene Editing - CRISPR Techn...
Epigenetics Market to climb to $16.3bn
October 30 by Chanice HenryA new research report from Grand View Research inc, charts that the international epigenetics market is due to reach US$16.31 billion by 2022. The forecasted growth being fuelled by the increasing f...
Connect with Pharma & Biotech Key Players - Your Ultimate Resource Pack
October 01 by Pharmaceuticals & Biotechnology EditorIn this whitepaper you will find out what it takes to successfully engage with pharma and biotech key players. Are you looking for a ways to showcase your solution in front of pharma and biotech i...
CRISPR CAS9 Emerging Technologies
September 14 by Pharma IQ NewsThe trailblazing CRISPR Cas9 technique has vastly widened the gene editing horizons for the R&D industry. The technique has been gaining popularity since its inception in 2013, with some job adver...
AstraZeneca: Discovering Drugs Through Partnerships
October 25 by Pharma IQDrug discovery projects are not cheap. The start of projects to consider new treatments for a range of diseases can be vast in their scope, meaning the development process can cost a significant amoun...
Public Private Partnerships: A Working Model for Open Innovation
June 15 by Pharma IQHow can we widen the real of pre-competitive science? Dr. Johan Weigelt, Chief Scientist of the Structural Genomics Consortium at the Karolinska Institute, joined Pharma IQ to discuss the...